0001209191-23-037750.txt : 20230616
0001209191-23-037750.hdr.sgml : 20230616
20230616125142
ACCESSION NUMBER: 0001209191-23-037750
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20230606
FILED AS OF DATE: 20230616
DATE AS OF CHANGE: 20230616
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Murray Lilian Shackelford
CENTRAL INDEX KEY: 0001743173
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37383
FILM NUMBER: 231020077
MAIL ADDRESS:
STREET 1: 228 BEACH ROAD
CITY: BELVEDERE
STATE: CA
ZIP: 94920
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arcadia Biosciences, Inc.
CENTRAL INDEX KEY: 0001469443
STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE PRODUCTION - CROPS [0100]
IRS NUMBER: 810571538
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 202 COUSTEAU PLACE
STREET 2: SUITE 105
CITY: DAVIS
STATE: X1
ZIP: 95618
BUSINESS PHONE: 530-756-7077
MAIL ADDRESS:
STREET 1: 202 COUSTEAU PLACE
STREET 2: SUITE 105
CITY: DAVIS
STATE: CA
ZIP: 95618
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-06
0
0001469443
Arcadia Biosciences, Inc.
RKDA
0001743173
Murray Lilian Shackelford
C/O ARCADIA BIOSCIENCES, INC.
5950 SHERRY LANE, SUITE 215
DALLAS
TX
75225
1
0
0
0
0
Stock Option (Right to Buy)
4.80
2023-06-06
4
A
0
937
0.00
A
2033-06-06
Common Stock
937
2378
D
The Option will become 100% vested and exercisable on the earlier to occur of (i) June 6, 2024 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service.
Lilian Shackelford Murray, by Attorney-in-fact, Solaeta Chan
2023-06-16
EX-24
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby constitutes and
appoints each of Thomas J. Schaefer, Matthew Connor and Solaeta Chan, signing
singly, the undersigned's true and lawful attorney-in-fact to:
(i) execute for and on behalf of the undersigned, in the undersigned's capacity
as an officer and/or director of Arcadia Biosciences, Inc. (the "Company"),
Forms 3, 4 and 5 (including amendments thereto), and for the purpose of filing
such Forms, to execute and deliver any documents necessary to the Securities and
Exchange Commission ("SEC") for the purpose of obtaining EDGAR codes, all in
accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended
(the "Exchange Act"), and the rules and regulations promulgated thereunder;
(ii) do and perform any and all acts for and on behalf of the undersigned that
may be necessary or desirable to complete and execute any such Forms 3, 4 or 5
and timely file such form (including amendments thereto) with the SEC and any
stock exchange or similar authority; and
(iii) take any other action of any type whatsoever in connection with the
foregoing that, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to such attorney-in-fact full power and authority
to do and perform any and every act and thing whatsoever requisite, necessary or
proper to be done in the exercise of any of the rights and powers herein
granted, as fully to all intents and purposes as the undersigned might or could
do if personally present, with full power of substitution and revocation, hereby
ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorney-in-fact, in
serving in such capacity at the request of the undersigned, is not assuming nor
is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Exchange Act.
The undersigned agrees that such attorney-in-fact may rely entirely on
information furnished orally or in writing by the undersigned to such
attorney-in-fact. The undersigned also agrees to indemnify and hold harmless the
Company and such attorney-in-fact against any losses, claims, damages or
liabilities (or actions in these respects) that arise out of or are based on any
untrue statement or omission of necessary facts in the information provided by
the undersigned to such attorney-in-fact for purposes of executing,
acknowledging, delivering and filing Forms 3, 4 or 5 (including amendments
thereto) and agrees to reimburse the Company and such attorney-in-fact for any
legal or other expenses reasonably incurred in connection with investigating or
defending against any such loss, claim, damage, liability or action.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 or 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier (a) revoked by the undersigned in a signed writing delivered to
the foregoing attorney-in-fact or (b) superseded by a new power of attorney
regarding the purposes outlined in the first paragraph hereof as of a later
date.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 10th day of March, 2023.
/s/ Lilian Shackelford Murray
______________________________
Signature
Lilian Shackelford Murray
______________________________
Print Name